NeuroSense Therapeutics Ltd. General And Administrative Expense
NeuroSense Therapeutics Ltd. (NRSN) reported General And Administrative Expense of $5.71 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:GeneralAndAdministrativeExpense · last filed 2024-04-04
| Period end | General And Administrative Expense 6 month | General And Administrative Expense 12 month |
|---|---|---|
| 2023-12-31 | $5.71M 20-F · filed 2024-04-04 | |
| 2023-06-30 | $3.11M 6-K · filed 2023-08-16 | |
| 2022-12-31 | $7.14M 20-F · filed 2024-04-04 | |
| 2022-06-30 | $3.69M 6-K · filed 2023-08-16 | |
| 2021-12-31 | $2.50M 20-F · filed 2024-04-04 | |
| 2021-06-30 | $545.00K 6-K/A · filed 2023-01-19 | |
| 2020-12-31 | $393.00K 20-F · filed 2023-03-22 | |
| 2019-12-31 | $337.00K 20-F · filed 2022-04-14 |